New conotoxin SO-3 targeting N-type voltage-sensitive calcium channels

Marine Drugs

Volumn 4, Issue 3, 2006, Pages 215-227

  Wen, Lei ^a,b   Yang, Sheng ^a   Zhou, Wenxia ^a   Zhang, Yongxiang ^a   Huang, Peitang ^c  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

MVIIA; N type calcium channel blockers; Pain; SO 3; Voltage sensitive calcium channels; conotoxins

Indexed keywords

CALCIUM CHANNEL N TYPE; CONOTOXIN; OMEGA CONOTOXIN MVIIA; OMEGA CONOTOXIN MVIIC; OMEGA CONOTOXIN SVIB; SO 3; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANALGESIA; ANXIETY; BIOLOGICAL ACTIVITY; BLURRED VISION; DIZZINESS; DRUG EFFECT; DRUG STRUCTURE; HALLUCINATION; HYPOTENSION; NONHUMAN; NYSTAGMUS; PAIN; REVIEW; SEDATION;

CONUS STRIATUS;

EID: 33646806510     PISSN: 16603397     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md403215     Document Type: Review

References (62)

1. Olivera, B. M.; Cruzab, L. J. Conotoxins, in retrospect. Toxicon 2001, 39, 7-14.
2. Terlau, H.; Olivera, B. M. Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol. Rev. 2004, 84, 41-68.
3. Wang, C. Z.; Chi, C. W. Conus peptides-a rich pharmaceutical treasure. Acta Biochim. Biophys. Sin. 2004, 36, 713-723.
4. Staats, P. S.; Yearwood, T.; Charapata, S. G.; Presley, R. W.; Wallace, M. S.; Byas-Smith, M.; Fisher, R.; Bryce, D. A.; Mangieri, E. A.; Luther, R. R.; Mayo, M.; Mcguire, D.; Ellis, D. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 2004, 291, 63-70.
5. Sharp, D. Novel pain relief via marine snails. Lancet 2005, 366, 439-440.
6. Lu, B. S.; Yu, F.; Zhao, D.; Huang, P. T.; Huang, C. F. Conopeptides from Conus striatus and Conus textile by cDNA cloning. Peptides 1999, 20, 1139-1144.
7. Lu, B. S.; Yu, F.; Wang, J. H.; Zhao, S. Q.; Zhao, D.; Dai, Q. Y.; Huang, P. T.; Huang, C. F. New O-superfamily conotoxins from Conus striatus inhabited near Chinese Hainan Island. Chin. Sci. Bull. 2000, 45, 432-435.
8. Ramilo, C. A.; Zafaralla, G. C.; Nadasdi, L.; Hammerland, L. G.; Yoshikami, D.; Gray, W. R.; Kristipati, R.; Ramachandran, J.; Miljanich, G.; Olivera, B. M. Novel α- and ω-conotoxins from Conus striatus venom. Biochemistry 1992, 31, 9919-9926.
9. Dai, Q. Y.; Liu, F. Y.; Zhou, Y. R.; Lu, B. S.; Yu, F.; Huang, P. T. The synthesis of SO-3, a conopeptide with high analgesic activity derived from Conus striatus. J. Nat. Prod. 2003, 66, 1276-1279.
10. Liu, F. Y.; Dai, Q. Y.; Li, J. J.; Li, X. L.; Zhou, Y. R.; Huang, P. T. SO3-a new type of conotoxin with analgesic activity. Bull. Acad. Mil. Med. Sci. 2001, 25, 174-176, 179.
11. Liu, F. Y.; Dai, Q. Y.; Zhou, Y. R.; Li, X. L.; Huang, P. T. Studies on toxicity and drug dependence of conotoxin peptide SO3. Letters in Biotechnology 2002, 13, 191-193, 213.
12. Wen, L.; Yang, S.; Qiao, H. F.; Liu, Z. W.; Zhou, W. X.; Zhang, Y. X.; Huang, P. T. SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons. Br. J. Pharmacol. 2005, 145, 728-739.
13. Zhou, Y. R.; Liu, F. Y.; Dai, Q. Y. Research on the relationship between refolding and bioactivity of the new type of conotoxin SO3. Letters in Biotechnology 2001, 12, 181-183.
14. Zhou, Y. R.; Liu, F. Y.; Dai, Q. Y.; Huang, P. T. Optimization of synthetic and folding conditions of a novel ω-conotoxin peptide SO3. Letters in Biotechnology 2002, 13, 286-288.
15. Zhou, Y. R.; Liu, F. Y.; Dai, Q. Y. Synthesis of ω-conotoxin and its derivatives. Journal of Chinese Biotechnology 2003, 23, 72-76.
16. Olivera, B. M.; McIntosh, J. M.; Cruz, L. J.; Luque, F. A.; Gray, W. R. Purification and sequence of a presynaptic peptide toxin from Conus geographus venom. Biochemistry 1984, 23, 5087-5090.
17. Olivera, B. M.; Cruz, L. J.; de Santos, V.; LeCheminant, G. W.; Griffin, D.; Zeikus, R.; McIntosh, J. M.; Galyean, R.; Varga, J.; Gray, W. R. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using ω-conotoxin from Conus magus venom. Biochemistry 1987, 26, 2086-2090.
18. 2+ channels. Neuron 1992, 9, 69-77.
19. Lewis, R. J.; Nielsen, K. J.; Craik, D. J.; Loughnan, M. L.; Adams, D. A.; Sharpe, I. A.; Luchian, T.; Adams, D. J.; Bond, T.; Thomas, L.; Jones, A.; Matheson, J. L.; Drinkwater, R.; Andrews, P. R.; Alewood, P. F. Novel ω-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J. Biol. Chem. 2000, 275, 35335-35344.
20. Miljanich, G. P., Ramachandran, J. Antagonists of neuronal calcium channels: structure, function, and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 707-734.
21. Fainzilber, M.; Lodder, J. C.; van der Schors, R. C.; Li, K. W.; Yu, Z.; Burlingame, A. L.; Geraerts, W. P.; Kits, K. S. A novel hydrophobic ω-conotoxin blocks molluscan dihydropyridine-sensitive calcium channels. Biochemistry 1996, 35, 8748-8752.
22. Sasaki, T.; Feng, Z. P.; Scott, R.; Grigoriev, N.; Syed, N. I.; Fainzilber, M.; Sato, K. Synthesis, bioactivity, and cloning of the L-type calcium channel blocker ω-conotoxin TxVII. Biochemistry 1999, 38, 12876-12884.
23. Currie, K. P. M.; Fox, A. P. Comparison of N- and P/Q-type voltage-gated calcium channel current inhibition. J. Neurosci. 1997, 17, 4570-4579.
24. 2+ current in hippocampal and dorsal root ganglion neurons of the rat. Mol. Pharmacol. 1998, 54, 559-568.
25. Blalock, E. M.; Porter, N. M.; Landfield, P. W. Decreased G-protein-mediated regulation and shift in calcium channel types with age in hippocampal cultures. J. Neurosci. 1999, 19, 8674-8684.
26. Scamps, F.; Vigues, S.; Restituito, S.; Campo, B.; Roig, A.; Charnet, P.; Valmier, J. Sarco-endoplasmic ATPase blocker 2, 5-di (tert-butyl)-1, 4-benzohydroquinone inhibits N-, P-, and Q- but not T-, L-, or R-type calcium currents in central and peripheral neurons. Mol. Pharmacol. 2000, 58, 18-26.
27. Bell, T. J.; Thaler, C.; Castiglioni, A. J.; Helton, T. D.; Lipscombe, D. Cell-specific alternative splicing increases calcium channel current density in the pain pathway. Neuron 2004, 41, 127-138.
28. Kim, J. I.; Takahashi, M.; Ohtake, A.; Wakamiya, A.; Sato, K. Tyr13 is essential for the activity of ω-conotoxin MVIIA and GVIA, specific N-type calcium channel blockers. Biochem. Biophys. Res. Commun. 1995, 206, 449-454.
29. Lew, M. J.; Flinn, J. P.; Pallaghy, P. K.; Murphy, R.; Whorlow, S. L.; Wright, C. E.; Norton, R. S.; Angus, J. A. Structure-function relationships of ω-conotoxin GVIA. Synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogs. J. Biol. Chem. 1997, 272, 12014-12023.
30. Nielsen, K. J.; Adams, D. A.; Alewood, P. F.; Lewis, R. J.; Thomas, L.; Schroeder, T.; Craik, D. J. Effects of chirality at Tyr13 on the structure-activity relationships of ω-conotoxins from conus magus. Biochemistry 1999, 38, 6741-6751.
31. Nielsen, K. J.; Schroeder, T.; Lewis, R. Structure-a ctivity relationships of ω-conotoxins at N-type voltage-sensitive calcium channels. J. Mol. Recognit. 2000, 13, 55-70.
32. 2+ channels. Annu. Rev. Cell Dev. Biol. 2000, 16, 521-555.
33. 2+ channels, cytoplasmic messengers and proteins of the synaptic vesicle release complex. Trends Pharmacol. Sci. 2001, 22, 519-525.
34. Arikkath, J.; Campbell, K. P. Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr. Opin. Neurobiol. 2003, 13, 298-307.
35. Catterall, W. A.; Striessnig, J. Snutch, T. P.; Perez-Reyes, E. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacol. Rev. 2003, 55, 579-581.
36. Yue, J. J.; Dai, Q. Y.; Wang, G. L.; Liang, L.; Yu, W. Y.; Huang, P. T. Computational simulation of interaction between calcium channel and conotoxin. Letters in Biotechnology 2002, 13, 281-285.
37. Nielsen, K. J.; Thomas, L.; Lewis, R. J.; Alewood, P. F.; Craik, D. J. A consensus structure for ω-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: comparison of MVIIA, SVIB and SNX-202. J. Mol. Biol. 1996, 263, 297-310.
38. Nielsen, K. J.; Adams, D.; Thomas, L.; Bond, T.; Alewood, P. F.; Craik, D. J.; Lewis, R. J. Structure-activity relationships of ω-conotoxins MVIIA, MVIIC and 1, 4 loop splice hybrids at N and P/Q-type calcium channels. J. Mol. Biol. 1999, 289, 1405-1421.
39. Kohno, T.; Kim, J.I.; Kobayashi, K.; Kodera, Y.; Maeda, T.; Sato, K. Three-dimensional structure in solution of the calcium channel blocker ω-conotoxin MVIIA. Biochemistry 1995, 34, 10256-10265.
40. Yan, Y. B.; Tu, G. Z.; Luo, X. C.; Dai, Q. Y.; Huang, P. T.; Zhang, R. Q. Three-dimensional solution structure of ω-conotoxin SO-3 determined by 1H NMR. Chin. Sci. Bull. 2003, 48, 1097-1102.
41. Williams, M. E.; Brust, P. F.; Feldman, D. H.; Patthi, S.; Simerson, S.; Maroufi, A.; McCue, A. F.; Velicelebi, G.; Ellis, S. B.; Harpold, M. M. Structure and functional expression of an ω-conotoxin-sensitive human N-type calcium channel. Science 1992, 257, 389-395.
42. Kristipati, R.; Nadasdi, L.; Tarczy-Hornoch, K.; Lau, K.; Miljanich, G. P.; Ramachandran, J.; Bell, J. R. Characterization of the binding of ω-Conopeptides to different classes of non-L-type neuronal calcium channels. Mol. Cell Neurosc. 1994, 5, 219-228.
43. 2+ channel in rat sympathetic ganglia and brain. Neuron 1997, 18, 153-166.
44. 2+ channels. J. Neurosci. 1997, 17, 3002-3013.
45. 1B subunit controls reversibility of ω-conotoxin GVIA and MVIIA block. J. Biol. Chem. 2001, 276, 15728-15735.
46. Liang, H.; Elmslie, K. S. Rapid and reversible block of N-type calcium channels (CaV 2.2) by ω-conotoxin GVIA in the absence of divalent cations. J. Neurosci. 2002, 22, 8884-8890.
47. Feng, Z. P.; Doering, C. J.; Winkfein, R. J.; Beedle, A. M.; Spafford, J. D.; Zamponi, G. W. Determinants of inhibition of transiently expressed voltage-gated calcium channels by ω-conotoxins GVIA and MVIIA. J. Biol. Chem. 2003, 278, 20171-20178.
48. v2.2) calcium channels. J. Biol. Chem. 2004, 279, 34705-34714.
49. Adams, D. J.; Smith, A. B.; Schroeder, C. I.; Yasuda, T.; Lewis, R. J. ω-Conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals. J. Biol. Chem. 2003, 278, 4057-4062.
50. 2+ channels. Neuroreport 2001, 12, 2423-2427.
51. 1B subunit of the voltage-dependent calcium channel. Mol. Cell Neurosci. 2001, 18, 235-245.
52. 2+ channel. EMBO J. 2001, 20, 2349-2356.
53. 2+ channels on pain transmission. Neurosci. Res. 2002, 43, 1-7.
54. Vanegasa, H.; Schaible, H. G. Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain 2000, 8, 9-18.
55. 2+ channels to treat pain: T-type versus N-type. Trends Pharmacol. Sci. 2004, 25, 465-470.
56. V 2.2) of N-type calcium channels. Proc. Natl. Acad. Sci. USA 2001, 98, 5323-5328.
57. V2.2) knock-out mice display hyperactivity and vigilance state differences. J. Neurosci. 2003, 23, 6793-6797.
58. Meir, A.; Ginsburg, S.; Butkevich, A.; Kachalsky, S. G.; Kaiserman, I.; Ahdut, R.; Demirgoren, S.; Rahamimoff, R. Ion channels in presynaptic nerve terminals and control of transmitter release. Physiol. Rev. 1999, 79, 1019-1088.
59. Bowersox, S. S.; Miljanich, G. P.; Sugiura, Y.; Li, C.; Nadasdi, L.; Hoffman, B. B.; Ramachandran, J.; Ko, C. P. Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel ω-conopeptides and ω-agatoxin-IVA. J. Pharmacol. Exp. Ther. 1995, 273, 248-256.
60. Katz, E.; Protti, D. A.; Ferro, P. A.; Rosato, S.; Uchitel, O. D. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction. Br. J. Pharmacol. 1997, 121, 1531-1540.
61. Scott, D. A.; Wright, C. E.; Angus, J. A. Actions of intrathecal ω-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur. J. Pharmacol. 2002, 451, 279-286.
62. Smith, M. T.; Cabot, P. J.; Ross, F. B.; Robertson, A. D.; Lewis, R. J. The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 2002, 96, 119-127.